282 related articles for article (PubMed ID: 17997601)
1. T cell responses to human endogenous retroviruses in HIV-1 infection.
Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
[TBL] [Abstract][Full Text] [Related]
2. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
[TBL] [Abstract][Full Text] [Related]
3. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and HERV expression: a review.
van der Kuyl AC
Retrovirology; 2012 Jan; 9():6. PubMed ID: 22248111
[TBL] [Abstract][Full Text] [Related]
5. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
Ormsby CE; Sengupta D; Tandon R; Deeks SG; Martin JN; Jones RB; Ostrowski MA; Garrison KE; Vázquez-Pérez JA; Reyes-Terán G; Nixon DF
PLoS One; 2012; 7(8):e41021. PubMed ID: 22879884
[TBL] [Abstract][Full Text] [Related]
6. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.
Tandon R; SenGupta D; Ndhlovu LC; Vieira RG; Jones RB; York VA; Vieira VA; Sharp ER; Wiznia AA; Ostrowski MA; Rosenberg MG; Nixon DF
J Virol; 2011 Nov; 85(21):11526-31. PubMed ID: 21880743
[TBL] [Abstract][Full Text] [Related]
7. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
8. Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons.
Lawoko A; Johansson B; Rabinayaran D; Pipkorn R; Blomberg J
J Med Virol; 2000 Dec; 62(4):435-44. PubMed ID: 11074471
[TBL] [Abstract][Full Text] [Related]
9. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between HERV-K expression and HIV-1 viral load in plasma specimens.
Esqueda D; Xu F; Moore Y; Yang Z; Huang G; Lennon PA; Hu PC; Dong J
Ann Clin Lab Sci; 2013; 43(2):122-5. PubMed ID: 23694785
[TBL] [Abstract][Full Text] [Related]
11. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.
Contreras-Galindo R; González M; Almodovar-Camacho S; González-Ramírez S; Lorenzo E; Yamamura Y
J Virol Methods; 2006 Sep; 136(1-2):51-7. PubMed ID: 16678919
[TBL] [Abstract][Full Text] [Related]
12. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
13. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
Front Immunol; 2018; 9():3092. PubMed ID: 30740110
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
15. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.
Streeck H; Brumme ZL; Anastario M; Cohen KW; Jolin JS; Meier A; Brumme CJ; Rosenberg ES; Alter G; Allen TM; Walker BD; Altfeld M
PLoS Med; 2008 May; 5(5):e100. PubMed ID: 18462013
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro.
Contreras-Galindo R; López P; Vélez R; Yamamura Y
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):116-22. PubMed ID: 17263641
[TBL] [Abstract][Full Text] [Related]
17. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies.
Liu CH; Grandi N; Palanivelu L; Tramontano E; Lin LT
Viruses; 2020 Aug; 12(8):. PubMed ID: 32759845
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
[TBL] [Abstract][Full Text] [Related]
20. Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.
Stevens RW; Baltch AL; Smith RP; McCreedy BJ; Michelsen PB; Bopp LH; Urnovitz HB
Clin Diagn Lab Immunol; 1999 Nov; 6(6):783-6. PubMed ID: 10548563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
